EDSA · ISSUER CIK 1540159
Edesa Biotech, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 1 Edesa Biotech, Inc. insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗1 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Oct 29, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 29, 202617:02 | Oct 28, 2026 | EDSA | Chief Executive Officer, Director, 10% Owner | A · Grant | — | +27,602 | 933,595 | +3% | — | ||
| Oct 6, 202617:05 | Oct 5, 2026 | EDSA | Chief Executive Officer, Director, 10% Owner | A · Grant | — | +6,893 | 905,993 | +1% | — | ||
| Sep 1, 202618:12 | Sep 1, 2026 | EDSA | Chief Executive Officer, Director, 10% Owner | A · Grant | — | +5,714 | 899,100 | +1% | — | ||
| Aug 4, 202617:02 | Aug 3, 2026 | EDSA | Chief Executive Officer, Director, 10% Owner | A · Grant | — | +5,324 | 893,386 | +1% | — |